Shanghai Fosun Pharmaceutical (Group) Co (SHSE:600196) ROCE % : 6.84% (As of Mar. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Shanghai Fosun Pharmaceutical (Group) Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shanghai Fosun Pharmaceutical (Group) Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 6.84%.

Shanghai Fosun Pharmaceutical (Group) Co ROCE % Historical Data

The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fosun Pharmaceutical (Group) Co ROCE % Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

10.03

9.46

11.18

8.03

5.98

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															8.98	8.46	5.18	1.79	6.84

Shanghai Fosun Pharmaceutical (Group) Co ROCE % Calculation

Shanghai Fosun Pharmaceutical (Group) Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	4589.398	/	( ( (107163.907 - 33298.069)	+	(113469.605 - 33757.584) )	/ 2 )
	=	4589.398	/	( (73865.838	+	79712.021)	/ 2 )
	=	4589.398	/	76788.9295
	=	5.98 %

Shanghai Fosun Pharmaceutical (Group) Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	5466.076	/	( ( (113469.605 - 33757.584)	+	(113745.789 - 33602.092) )	/ 2 )
	=	5466.076	/	( ( 79712.021	+	80143.697 )	/ 2 )
	=	5466.076	/	79927.859
	=	6.84 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Shanghai Fosun Pharmaceutical (Group) Co (SHSE:600196) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Shanghai Fosun Pharmaceutical (Group) Co ROCE % Related Terms

Thank you for viewing the detailed overview of Shanghai Fosun Pharmaceutical (Group) Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Fosun Pharmaceutical (Group) Co (SHSE:600196) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) » Definitions » ROCE %

Traded in Other Exchanges

SFOSF:USA 02196:Hong Kong 08HH:Germany

Address

No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233

Website

https://www.fosunpharma.com

Shanghai Fosun Pharmaceutical (Group) Co Ltd is a specialty and generic drug manufacturing company. Shanghai Fosun maintains five business segments, including Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. Most of the company's revenue is generated by its Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Executives

Bao Qin Gui	senior management
Guan Xiao Hui	Director
Mei Jing Ping	senior management
Li Sheng Li	senior management
Feng Rong Li	senior management
Wang Dong Hua	senior management
Wu Yi Fang	Director
Su Li	senior management
Dong Xiao Xian	senior management
Zhu Yue	senior management
Hu Hang	senior management
Chen Yu Qing	senior management
Liu Yi	senior management
Zhang Yue Jian	senior management
Wen De Yong	Directors, senior managers

Shanghai Fosun Pharmaceutical (Group) Co (SHSE:600196) Headlines

No Headlines